ENSC: the balance sheet

MyFinsight

For the year ending 2025-12-31, ENSC has $7,452,479 in assets. $4,567,729 in debts. $4,310,354 in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	4,310,354
Unbilled receivable	420,345
Prepaid expenses and other current assets	2,511,769
Total current assets	7,242,468
Property and equipment, net	124,129
Other assets	85,882
Total assets	7,452,479

Accounts payable	3,267,610
Accrued expenses and other liabilities	993,411
Notes payable and accrued interest	306,708
Total current liabilities	4,567,729
Total liabilities	4,567,729
Common stock, 0.0001 par value, 250,000,000 shares authorized at december 31, 2025 and december 31, 2024 4,574,983 and 1,355,779 shares issued at december 31, 2025 and december 31, 2024, respectively 4,574,977 and 1,355,773 shares outstanding at december 31, 2025 and december 31, 2024, respectively	459
Additional paid-in capital	142,933,260
Accumulated deficit	-139,719,999
Total ensysce biosciences, inc. stockholders equity	3,213,720
Noncontrolling interests in stockholders deficit	-328,970
Total stockholders equity	2,884,750
Total liabilities and stockholders equity	7,452,479

Unit: Dollar.